Susana Keranen-Rosello

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 21, 2026

Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred care.

Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred care.

Journal: ESMO open

Published: December 18, 2024

The Degree of Extramural Spread of T3 Colon Cancer as a Prognostic Factor: Another Appeal to the American Joint Committee on Cancer.

The Degree of Extramural Spread of T3 Colon Cancer as a Prognostic Factor: Another Appeal to the American Joint Committee on Cancer.

Journal: Cancer medicine

Published: October 09, 2024

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.

Journal: EBioMedicine

Published: March 27, 2024

Does month of birth influence colorectal cancer prognosis?

Does month of birth influence colorectal cancer prognosis?

Journal: Langenbeck's archives of surgery

Published: April 03, 2023

Evaluation of results after 112 radioembolizations with 90Y-microspheres.

Evaluation of results after 112 radioembolizations with 90Y-microspheres.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: March 31, 2023

Short-term outcomes of colorectal cancer surgery in older patients: a novel nomogram predicting postoperative morbi-mortality.

Short-term outcomes of colorectal cancer surgery in older patients: a novel nomogram predicting postoperative morbi-mortality.

Journal: Langenbeck's archives of surgery

Published: July 24, 2022

Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.

Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.

Journal: Frontiers in oncology

Published: May 19, 2021

Prognostic implications of surgical specimen quality on the oncological outcomes of open and laparoscopic surgery in mid and low rectal cancer.

Prognostic implications of surgical specimen quality on the oncological outcomes of open and laparoscopic surgery in mid and low rectal cancer.

Journal: Langenbeck's archives of surgery

Published: April 30, 2021

The actual management of colorectal liver metastases.

The actual management of colorectal liver metastases.

Journal: Minerva chirurgica

Published: August 11, 2020

Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients.

Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients.

Journal: Clinical lung cancer

Published: January 16, 2017

FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic disease.

FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic disease.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 03, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026